Hospitalist Doctors in Canton, GA Accepting Medicare

8 Hospitalist doctors found. Showing 1 - 8

Drake Christian Dehoff, MD Hospitalist Medicare: Medicare Enrolled Practice Location: 450 Northside Cherokee Blvd, Canton, GA 30115 Phone: 770-224-1000

Lindsey Hannah Panter, ACNP Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 450 Northside Cherokee Blvd, Canton, GA 30115 Phone: 770-224-2450

Grant Herron Moody, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 450 Northside Cherokee Blvd, Canton, GA 30115 Phone: 770-224-1000    Fax: 770-224-2451

Dr. Neil K. Sinha, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 460 Northside Cherokee Blvd Ste 370, Canton, GA 30115 Phone: 678-880-7021

Michael Anthony Martinelli, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 450 Northside Cherokee Blvd, Canton, GA 30115 Phone: 770-224-1388    Fax: 770-224-1386

Syed Nabi, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 201 Hospital Rd, Canton, GA 30114 Phone: 770-720-5100    Fax: 404-851-6325

Dr. Rodrigo M Mancheno, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 450 Northside Cherokee Blvd, Canton, GA 30115 Phone: 770-224-1000    Fax: 770-224-2451

Geoffrey Ngeny, MD Hospitalist Medicare: Medicare Enrolled Practice Location: 450 Northside Cherokee Blvd, Canton, GA 30115 Phone: 770-224-1000    Fax: 770-224-2451

News Archive

Investigation to find the source of the current SARS outbreak

Investigation of the source of the current outbreak, first reported on 22 April, continues to focus on the National Institute of Virology in Beijing. The institute is known to have conducted experiments using the live SARS coronavirus during February and March.

Novel antibacterial protein could prevent or treat E. coli O157:H7-induced food-borne infections

A novel antibacterial protein targeted against E. coli O157:H7 may offer a way to prevent or treat serious food-borne bacterial infections, as demonstrated in a study published in the December issue of Antimicrobial Agents and Chemotherapy.

Smoking and vaping significantly increase risk of COVID-19 in teens and young adults

Now, a new study published in the Journal of Adolescent Health shows that teens and young adults may have a heightened risk of COVID-19 if they vape or smoke cigarettes. Cigarette smokers are seven times more likely to be infected with SARS-CoV-2. Meanwhile, people who vape are five times more likely to be diagnosed with the viral infection.

Blood test developed for non-alcoholic fatty liver disease diagnosis

Scientists at the Basque Center for Cooperative Research in Biosciences (CIC bioGUNE) and OWL Genomics Ltd. (Bilbao, Spain), in collaboration with researchers at the INSERM and University Hospitals (APHP Pitié Salpêtrière Hospital, Pierre & Marie Curie University Paris and Centre Hospitalier Universitaire Nice, University of Nice-Sophia-Antipolis, Nice, France), Vanderbilt University (Nashville, US), the University of Southern California (Los Angeles, US), Clinic Hospital and IDIBAPS (Barcelona, Spain) and the Alcalá de Henares University (Alcalá de Henares, Spain) have used metabolomics technology to develop a blood test for non-alcoholic fatty liver disease (NAFLD) diagnosis.

Human Genome Sciences announces agreement with GSK for development of drug to treat diabetes

Human Genome Sciences today announced an agreement with GlaxoSmithKline under which GlaxoSmithKline has acquired exclusive worldwide rights to develop and commercialize Albugon (albumin-glucagon-like peptide-1, GLP-1), a drug currently in late-stage preclinical development by Human Genome Sciences for potential use in the treatment of diabetes.

Read more Medical News

› Verified 2 days ago